Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib Pre-Surgical Phase 2 Study in Patients with Primary Breast Cancer
2006-001055-35Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lapatinib in breast cancer, sponsored by Imperial College London. Primary endpoint: RECIST response by ultrasound. Started Feb 2008; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-001055-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001055-35.